Sign in
Taking people in United StatesPhase 2/3

Comparing two ways to help the stomach empty after esophagus surgery

Compares Botox injection with pyloromyotomy in adults having esophagus surgery.

Key facts

Who runs it
The Cleveland Clinic
Where
Cleveland, United StatesSee the site
Trial code
Registry title
Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
Status
Recruiting
Phase
Phase 2/3
People taking part
170 people, planned
Started
3 Dec 2024
Expected to end
31 May 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Botulinum Toxin A (Botox )
  • Pyloromyotomy
Record updated
25 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are having a planned esophagectomy (surgery to remove the esophagus) and will have their stomach used to rebuild the food pathway. It compares two ways of helping the stomach empty: a Botox injection into the pylorus or a pyloromyotomy.

Age
18 years or older
Sex
All sexes can join
Disease stage
Planned (elective) esophagectomy with a gastric conduit for reconstruction, for benign or malignant esophageal disease. The surgeon must be able to do either method during the operation.

Main reasons for not taking part

  • Emergency esophagectomy (for example, for a perforated esophagus)
  • Neuromuscular disease such as amyotrophic lateral sclerosis, myasthenia gravis, muscular dystrophies or Lambert-Eaton syndrome
  • Sweet esophagectomy without a left neck incision
  • Pregnancy
  • Allergy or hypersensitivity to botulinum toxin

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • 18 years of age or older
  • Undergoing elective esophagectomy (thoracoabdominal, Ivor-Lewis, McKeown)
  • Receiving a gastric conduit for alimentary reconstruction
  • Technically able to receive either intrapyloric Botox injection or pyloromyotomy as ultimately determined intraoperatively
  • Willing and able to provide informed consent
  • Willing and able to participate in long-term follow up including study visits and surveys

Who cannot take part

  • Patients undergoing left thoracoabdominal without left cervical neck incision (i.e., Sweet esophagectomy) - excluded due to the extent of gastric resection
  • Undergoing emergent esophagectomy (e.g., for esophageal perforation)
  • Patients with underlying neuromuscular disease as Botox would be contraindicated (amyotrophic lateral sclerosis, myasthenia gravis, muscular dystrophies, Lambert-Eaton syndrome)
  • Allergy or hypersensitivity to botulinum toxin
  • Pregnancy
  • Cannot feasibly receive both pyloric interventions as determined intraoperatively (e.g., patients with central obesity undergoing thoracoabdominal esophagectomy makes for a technically difficult pyloromyotomy)

Where in United States

  • Cleveland ClinicCleveland, United StatesContact: Andrew Conner, MDTaking people

About the trial

What the trial wants to find out

The goal of this pragmatic, registry-based, randomized clinical trial is to find out if using botulinum toxin (Botox) to help drain the stomach during an esophagectomy works as well as a pyloromyotomy in patients undergoing elective esophagectomy for benign or malignant esophageal disease. Both methods are intended to prevent problems with food emptying too slowly from the stomach (delayed gastric emptying), which can cause discomfort after surgery. The main question it aims to answer is:

Read full original descriptionShow less

Is intrapyloric Botox injection as a drainage procedure during esophagectomy non-inferior in preventing symptoms of delayed gastric emptying at 6 months postoperatively compared to pyloromyotomy?

Researchers will compare intrapyloric Botox injection to pyloromyotomy to see if Botox is non-inferior to pyloromyotomy in easing symptoms of delayed gastric emptying.

Participants will:

Be randomized to one of two treatment groups-either intrapyloric Botox injection or pyloromyotomy-during their esophagectomy.

Complete surveys assessing digestive symptoms at standard postoperative follow-up intervals (3 months, 6 months, 1 year, and 2 years postoperatively).

Undergo a standard gastric emptying study at 6 months after surgery.

The 2 groups in the trial

  • BotoxTreatment being tested

    Patients will be randomized to the intrapyloric Botox injection intervention arm intraoperatively just after the pylorus is identified and just prior to the time at which pyloric drainage would occur routinely, at which point it is feasible for the surgeon to perform either intervention.

    Treatment: Botulinum Toxin A (Botox )

  • PyloromyotomyExisting treatment, for comparison

    Patients will be randomized to the pyloromyotomy intervention arm intraoperatively just after the pylorus is identified and just prior to the time at which pyloric drainage would occur routinely, at which point it is feasible for the surgeon to perform either intervention.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparative Effectiveness of Intrapyloric Botulinum Toxin Injection Versus Pyloromyotomy for Pyloric Drainage During Esophagectomy: A Registry-Based, Pragmatic Randomized Noninferiority Trial
Plain-language title
Comparing two ways to help the stomach empty after esophagus surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
25 February 2026